![]() |
市場調查報告書
商品編碼
1305177
全球自動內視鏡後處理市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測Global Automated Endoscope Reprocessors Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
據預測,到2030年,全球自動內視鏡後處理市場的需求將從2022年的4.3532億美元達到近8.1294億美元,2023-2030年的複合年成長率為8.12%。在產量方面,2022年的市場容量為XX台,預計到2030年將達到XX台,2023-2030年的複合年成長率為XX%。
自動內視鏡再處理機(AER)是用於清洗和消毒使用後的軟性內視鏡的醫療設備。軟性內視鏡是一種細長的器械,末端裝有照明燈和鏡頭,用於觀察和執行體內手術,如胃腸道或呼吸系統手術。 AER旨在實現內視鏡清洗和消毒過程的自動化,這是預防感染和確保患者安全的關鍵步驟。 AER結合使用高級消毒劑和自動清潔循環,清除內視鏡上殘留的任何生物材料或污染物。
全球內視鏡手術的日益普及是AER市場的主要驅動力。內視鏡手術作為各種疾病的診斷和治療工具正變得越來越普遍,包括胃腸道、呼吸道和泌尿系統疾病。有關AER使用的監管審查和指導方針不斷增加,導致對這些設備的需求增加。美國FDA和歐洲EMA對AER的設計、測試和使用制定了嚴格的指導方針,以確保其安全性和有效性。醫療機構對感染控制的日益重視也推動了對AER的需求。正確清洗和消毒內視鏡對於防止傳染源傳播和降低醫療相關感染風險至關重要。自動清洗消毒器的技術進步促進了更高效、更有效的清洗和消毒過程的發展。較新的AER設計有自動檢漏、電子追踪系統和先進的消毒循環等功能,提高了再處理過程的安全性和可靠性。一次性內視鏡和附件的需求不斷成長,導致市場轉向能夠處理這些設備的自動清洗機。製造商正在開發既可重複使用又可一次性使用的設備,以滿足醫療機構不斷變化的需求。對於醫療機構來說,自動清洗消毒機是一種具有成本效益的解決方案,因為它們可以減少對昂貴的人工清洗和消毒過程的需求。它們還有助於延長內視鏡的使用壽命,減少頻繁更換的需要。
研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰了解行業結構,評估全球競爭吸引力。此外,這些工具還對全球自動內視鏡後處理市場的各個細分市場進行了全面評估。自動內視鏡再處理機行業的成長和趨勢為本研究提供了整體方法。
自動內視鏡再處理機市場報告的這一部分提供了國家和地區層面細分市場的詳細數據,從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域展望,重點介紹北美、歐洲、亞太、拉丁美洲、中東和非洲地區內視鏡自動再處理系統市場的當前和未來需求。此外,報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場中主要企業的綜合概況以及全球競爭格局的深入分析。自動內視鏡後處理市場的主要參與者包括Custom Ultrasonics Inc.、STERIS Plc.、Hoya Corporation、Olympus Corporation、Advanced Sterilization Products Services Inc、Laboratory Anios、Getinge AB、Metull Zug AG、Steelco SpA、Cantel Medical Corp.、Johnson & Johnson。本節包括競爭格局的整體視圖,其中包括各種戰略發展,如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。
*注:在公司概況中,財務細節和近期發展取決於可用性,如果是私營公司,則可能不包括在內。
The global demand for Automated Endoscope Reprocessors Market is presumed to reach the market size of nearly USD 812.94 MN by 2030 from USD 435.32 MN in 2022 with a CAGR of 8.12% under the study period 2023 - 2030. Regarding volume, the market was calculated XX Units in 2022 and forecast to touch XX Units by 2030 with a CAGR of XX% during 2023-2030.
Automated Endoscope Reprocessors (AERs) are medical devices used to clean and disinfect flexible endoscopes after use. Flexible endoscopes are long, thin instruments with a light and camera on the end that are used to visualize and perform procedures inside the body, such as in the gastrointestinal tract or respiratory system. AERs are designed to automate the process of cleaning and disinfecting endoscopes, which is a critical step in preventing infections and ensuring patient safety. AERs use a combination of high-level disinfectants and automated cleaning cycles to remove any remaining biological material or contaminants on the endoscope.
The increasing prevalence of endoscopic procedures worldwide is a major driver of the AERs market. Endoscopic procedures are becoming more common as a diagnostic and treatment tool for various medical conditions, including gastrointestinal, respiratory, and urological disorders. The increasing regulatory scrutiny and guidelines on the use of AERs have led to increased demand for these devices. US FDA and the European EMA have set strict guidelines for the design, testing, and use of AERs to ensure their safety and efficacy. The growing focus on infection control in healthcare facilities has also driven the demand for AERs. Properly cleaned and disinfected endoscopes are critical for preventing the transmission of infectious agents and reducing the risk of healthcare-associated infections. Technological advancements in AERs have led to the development of more efficient and effective cleaning and disinfection processes. Newer AERs are designed with features such as automated leak testing, electronic tracking systems, and advanced disinfection cycles that improve the safety and reliability of the reprocessing process. The growing demand for single-use endoscopes and accessories has led to a shift in the market towards AERs that can handle these devices. Manufacturers are developing AERs that can reprocess both reusable and single-use devices to meet the changing needs of healthcare facilities. AERs are a cost-effective solution for healthcare facilities as they can reduce the need for costly manual cleaning and disinfection processes. They can also help to extend the lifespan of endoscopes, reducing the need for frequent replacements.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of automated endoscope reprocessors. The growth and trends of automated endoscope reprocessors industry provide a holistic approach to this study.
This section of the automated endoscope reprocessors market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Automated Endoscope Reprocessors market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the automated endoscope reprocessors market include Custom Ultrasonics Inc., STERIS Plc., Hoya Corporation, Olympus Corporation, Advanced Sterilization Products Services Inc, Laboratory Anios, Getinge AB, Metull Zug AG, Steelco S.p.A., Cantel Medical Corp., Johnson & Johnson. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies